E.C.I. Veerman

2.1k total citations
35 papers, 1.7k citations indexed

About

E.C.I. Veerman is a scholar working on Physiology, Molecular Biology and Periodontics. According to data from OpenAlex, E.C.I. Veerman has authored 35 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 14 papers in Molecular Biology and 11 papers in Periodontics. Recurrent topics in E.C.I. Veerman's work include Salivary Gland Disorders and Functions (19 papers), Oral microbiology and periodontitis research (10 papers) and Glycosylation and Glycoproteins Research (9 papers). E.C.I. Veerman is often cited by papers focused on Salivary Gland Disorders and Functions (19 papers), Oral microbiology and periodontitis research (10 papers) and Glycosylation and Glycoproteins Research (9 papers). E.C.I. Veerman collaborates with scholars based in Netherlands, Chile and Denmark. E.C.I. Veerman's co-authors include A. van Nieuw Amerongen, A. van Nieuw Amerongen, Yvonne Henskens, Arjan Vissink, Jan G.M. Bolscher, H.S. Brand, U. van der Velden, W.A. van der Reijden, Wim van ‘t Hof and Elisabeth Bloemena and has published in prestigious journals such as Journal of Biological Chemistry, Biomaterials and Journal of Controlled Release.

In The Last Decade

E.C.I. Veerman

35 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E.C.I. Veerman Netherlands 23 629 535 400 254 237 35 1.7k
A. van Nieuw Amerongen Netherlands 21 869 1.4× 784 1.5× 579 1.4× 301 1.2× 217 0.9× 59 1.9k
A. van Nieuw Amerongen Netherlands 25 620 1.0× 522 1.0× 436 1.1× 112 0.4× 148 0.6× 66 1.6k
E.C.I. Veerman Netherlands 30 1.2k 1.8× 1.1k 2.0× 899 2.2× 329 1.3× 268 1.1× 69 3.1k
Michael J. Levine United States 23 651 1.0× 1.0k 1.9× 766 1.9× 268 1.1× 106 0.4× 38 2.2k
Pekka Vilja Finland 29 593 0.9× 540 1.0× 504 1.3× 82 0.3× 179 0.8× 67 2.3k
U. Dahlgren Sweden 26 231 0.4× 299 0.6× 543 1.4× 80 0.3× 181 0.8× 112 2.2k
C. A. Squier United States 26 224 0.4× 341 0.6× 513 1.3× 64 0.3× 222 0.9× 65 2.0k
Takao Hirofuji Japan 27 330 0.5× 994 1.9× 418 1.0× 76 0.3× 95 0.4× 77 1.9k
A. Rizzo Italy 26 162 0.3× 280 0.5× 468 1.2× 230 0.9× 171 0.7× 69 1.9k
Yoshihiro Abiko Japan 29 257 0.4× 519 1.0× 1.0k 2.5× 532 2.1× 235 1.0× 152 2.5k

Countries citing papers authored by E.C.I. Veerman

Since Specialization
Citations

This map shows the geographic impact of E.C.I. Veerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.C.I. Veerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.C.I. Veerman more than expected).

Fields of papers citing papers by E.C.I. Veerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.C.I. Veerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.C.I. Veerman. The network helps show where E.C.I. Veerman may publish in the future.

Co-authorship network of co-authors of E.C.I. Veerman

This figure shows the co-authorship network connecting the top 25 collaborators of E.C.I. Veerman. A scholar is included among the top collaborators of E.C.I. Veerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.C.I. Veerman. E.C.I. Veerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karagozoglu, K. Hakki, et al.. (2014). Salivary stones: symptoms, aetiology, biochemical composition and treatment. BDJ. 217(11). E23–E23. 81 indexed citations
2.
Ligtenberg, A.J.M., et al.. (2013). Bacillus globigii cell size is influenced by variants of the quorum sensing peptide extracellular death factor. Antonie van Leeuwenhoek. 105(1). 221–228. 2 indexed citations
3.
Brand, H.S., et al.. (2009). The erosive potential of lollipops. International Dental Journal. 59(6). 358–362. 15 indexed citations
5.
Alliende, Cecilia, YJ Kwon, Michael dos Santos Brito, et al.. (2007). Reduced sulfation of muc5b is linked to xerostomia in patients with Sjögren syndrome. Annals of the Rheumatic Diseases. 67(10). 1480–1487. 48 indexed citations
6.
Bots, C.P., H.S. Brand, E.C.I. Veerman, et al.. (2007). Acute effects of hemodialysis on salivary flow rate and composition. Clinical Nephrology. 67(1). 25–31. 27 indexed citations
7.
Brand, H.S., et al.. (2006). The oral health status of dentate patients with chronic renal failure undergoing dialysis therapy. Oral Diseases. 12(2). 176–180. 109 indexed citations
8.
Veerman, E.C.I., et al.. (2003). Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Supportive Care in Cancer. 11(4). 226–231. 102 indexed citations
9.
Hof, Wim van ‘t, E.C.I. Veerman, Eva J. Helmerhorst, & A. van Nieuw Amerongen. (2001). Antimicrobial peptides: properties and applicability. Journal of Biological Chemistry. 382. 597–619. 110 indexed citations
10.
Lie, M. A., B.G. Loos, Yvonne Henskens, et al.. (2001). Salivary cystatin activity and cystatin C in natural and experimental gingivitis in smokers and non‐smokers. Journal Of Clinical Periodontology. 28(10). 979–984. 32 indexed citations
11.
Reijden, W.A. van der, et al.. (1999). Evaluation of the use of xanthan as vehicle for cationic antifungal peptides. Journal of Controlled Release. 60(1). 49–56. 25 indexed citations
12.
Vissink, Arjan, et al.. (1999). Treatment of oral dryness related complaints (xerostomia) in Sjögren's syndrome. Annals of the Rheumatic Diseases. 58(8). 465–474. 46 indexed citations
13.
Groenink, Jasper, Els Walgreen-Weterings, Kamran Nazmi, et al.. (1999). Salivary lactoferrin and low‐Mr mucin MG2 in Actinobacillus actinomycetemcomitans‐associated periodontitis. Journal Of Clinical Periodontology. 26(5). 269–275. 80 indexed citations
14.
Amerongen, A. van Nieuw, Jan G.M. Bolscher, Elisabeth Bloemena, & E.C.I. Veerman. (1998). Review. Biological Chemistry. 379(1). 1–26. 112 indexed citations
15.
Henskens, Yvonne, E.C.I. Veerman, & A. van Nieuw Amerongen. (1996). Review. Biological Chemistry Hoppe-Seyler. 377(2). 71–120. 153 indexed citations
16.
Veerman, E.C.I., et al.. (1996). Human glandular salivas: their separate collection and analysis. European Journal Of Oral Sciences. 104(4). 346–352. 190 indexed citations
17.
Reijden, W.A. van der, et al.. (1996). Analysis of the concentration and output of whole salivary constituents in patients with Sjögren's syndrome. European Journal Of Oral Sciences. 104(4). 335–340. 47 indexed citations
18.
Vissink, Arjan, et al.. (1995). Development and in vivo evaluation of polymer-based saliva substitutes.. Journal of Dental Research. 74. 547–547. 2 indexed citations
19.
Schenkels, L.C.P.M., J. Schaller, Els Walgreen-Weterings, et al.. (1994). Identity of Human Extra Parotid Glycoprotein (EP-GP) with Secretory Actin Binding Protein (SABP) and Its Biological Properties. Biological Chemistry Hoppe-Seyler. 375(9). 609–616. 37 indexed citations
20.
Amerongen, A. van Nieuw, et al.. (1993). Biochemical Changes in (Glyco)proteins of Saliva of Epileptic Patients. Annals of the New York Academy of Sciences. 694(1). 283–285. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026